Showing results for south dakota
Each Saturday, we have been running a series of blog posts that take a close look at each of the Democratic Party candidates for President in 2020. We examine each candidate’s historic approach to marijuana law and policy, and we also canvas their current respective stances on marijuana. Over the past four weeks, we covered Joe
Over the last few weeks, the federal government has taken a number of actions that signal a dark future for psychedelic therapies. Today we’ll take a quick look at what’s happened, and what may happen in the future. FDA gives thumbs down to MDMA Earlier in August, the FDA opted not to approve Lykos Therapeutics’
It’s hard to believe that we are wrapping up the first year of the Oregon Psilocybin Services (OPS) program. Final rules were released at this time last year, following a protracted, two-year development period. The application window for licenses opened timely on January 2, 2023, and the Oregon Health Authority (OHA) continues to administer this
A few weeks ago, we held a webinar about ketamine regulation and the future of psychedelic medicine (for a recording, click here). At the time, there were big changes on the horizon for ketamine telehealth. In the last few weeks, there have been a few pretty significant developments that merit some attention. For some background,
We’ve discussed at length the DEA’s process for seeking religious exemptions to the Controlled Substances Act (CSA). You can read about that in my posts linked at the bottom of this one. Critics of the religious exemption petition process claim that the DEA rarely, if ever, responds to petitions. They also complain that they are
International Supply Chain Risks As I write this, nearly 50 Hezbollah terrorists are dead, and 3,000 or so more are lying in hospitals with severe injuries caused by Made in Taiwan/Made in Hungary pagers infused with explosive material. This pager explosion operation, likely orchestrated by Mossad with the help of the IDF and Druze and
United States Antidumping Cases Companies importing products into the United States from China may be unfamiliar with terms such as “non-market economy (NME),” “respondent,” and “surrogate values.” However, this quickly changes when such companies’ imported goods are subject to a U.S. antidumping proceeding. U.S. antidumping or “AD” cases are complex. This is especially true for
High-Quality Dispute Resolution Clauses With sushi restaurants, it’s the yellowfin. With new houses, it’s the windows. With international contracts, it’s the dispute resolution provision. The “it” I am talking about is the easiest, fastest, most accurate way to judge whether something is good or not. For international contracts, I head straight to the dispute resolution
Introduction I am an international transactions lawyer. I frequently handle the initial stages of transactions and often find myself negotiating with parties who do not have legal representation. In these scenarios, I am trying to put together the easiest and most streamlined contract that the counterparty will be comfortable with. This work requires a deep
The Deteriorating US-China Relationship The US-China relationship has been deteriorating for years, but it continues to worsen with no end in sight. Doing business with Chinese companies is going to become increasingly difficult. Below we outline some of our concerns and some of the steps our international lawyers have seen businesses take to prepare themselves
